zurück zur Startseite
Zentrale Tel.: 06221-560

Publikationen 2007

Wagener N, Crnkovic-Mertens I, Vetter C, Macher-Goppinger S, Bedke J, Grone EF, Zentgraf H, Pritsch M, Hoppe-Seyler K, Buse S, Haferkamp A, Autschbach F, Hohenfellner M, Hoppe-Seyler F
Expression of inhibitor of apoptosis protein Livin in renal cell carcinoma and non-tumorous adult kidney.
Br J Cancer. 2007 Nov 5;97(9):1271

Haferkamp A, Bastian PJ, Jakobi H, Pritsch M, Pfitzenmaier J, Albers P, Hallscheidt P, Muller SC, Hohenfellner M.
Renal cell carcinoma with tumor thrombus extension into the vena cava: prospective long-term followup.
J Urol. 2007 May;177(5):1703-8.

Crnkovic-Mertens I, Wagener N, Semzow J, Grone EF, Haferkamp A, Hohenfellner M, Butz K, Hoppe-Seyler F.
Targeted inhibition of Livin resensitizes renal cancer cells towards apoptosis.
Cell Mol Life Sci. 2007 May;64(9):1137-44

Buse S, Reitz A, Haferkamp A, Hohenfellner M.
Conservative treatment of male stress incontinence
Urologe A. 2007 Mar;46(3):240-3

Neuhof D, Hentschel T, Bischof M, Sroka-Perez G, Hohenfellner M, Debus J
Long-term results and predictive factors of three-dimensional conformal salvage radiotherapy for biochemical relapse after prostatectomy.
Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1411-7

Zhang C, Wenger T, Mattern J, Ilea S, Frey C, Gutwein P, Altevogt P, Bodenmuller W, Gassler N, Schnabel PA, Dienemann H, Marme A, Hohenfellner M, Haferkamp A, Pfitzenmaier J, Grone HJ, Kolb A, Buchler P, Buchler M, Friess H, Rittgen W, Edler L, Debatin KM, Krammer PH, Rutz HP, Herr I.
Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors.
Cancer Biol Ther. 2007 Feb;6(2):278-8

Haferkamp A, Hohenfellner M.
Medical treatment options in patients with metastatic renal cell carcinoma.
Nephrol Dial Transplant. 2007 Apr;22(4):996-9

Buse S, Bedke J, Kurosch M, Haferkamp A, Unterberg A, Herfarth K, Hohenfellner M.
Brain metastases in cases of renal cell carcinoma
Urologe A. 2007 Jan;46(1):36-9

Kurosch M, Buse S, Bedke J, Wagener N, Haferkamp A, Hohenfellner M
Palliative and supportive therapy in cases of renal cell carcinoma
Urologe A. 2007 Jan;46(1):40-4. German.

Bedke J, Buse S, Kurosch M, Haferkamp A, Jager D, Hohenfellner M.
Paraneoplastic syndrome in renal cell carcinoma
Urologe A. 2007 Jan;46(1):45-8

Basra R, Artibani W, Cardozo L, Castro-Diaz D, Chapple C, Cortes E, De Ridder D, Pons ME, Haab F, Hohenfellner M, Kirby M, Milsom I, Van Kerrebroeck P, Vierhout M, Wagg A, Kelleher C.
Design and validation of a new screening instrument for lower urinary tract dysfunction: the bladder control self-assessment questionnaire (B-SAQ).
Eur Urol. 2007 Jul;52(1):230-7

Kurosch M, Haferkamp A, Pritsch M, Wagener N, Riedasch G, Hohenfellner M Imperative Nierenzellkarzinom (NCC) - Resektionen – Prognosefaktoren für das Langzeitüberleben des Patienten
Der Urologe 46 (Suppl 1): S95, 2007

Nyarangi-Dix J.N, Djakovic N, Haferkamp A, Pfitzenmaier J, Bedke J, Buse S,
Hohenfellner M
Genitalrekonstruktion mit gestieltem Leistenlappen bei monströser Skrotalhernie
Der Urologe 46 (Suppl 1): S54, 2007

Buse S, Gilfrich C, Pfitzenmaier J, Djakovic N, Bedke J, Pahernik S, Haferkamp A,
Hohenfellner M
Gleichzeitige GIA-STAPLER Ligatur des Niernstiels während laparoskopischer
Nephrektomie

Der Urologe 46 (Suppl 1): S108, 2007

Pfitzenmaier J, Haferkamp A, Pritsch M, Jakobi H, Gilfrich C, Djakovic N,
Buse S, Pahernik S, Hohenfellner M
Der Body Mass Index (BIM) stellt keinen Progenosefaktor nach radikaler Prostatektomie (RPx) dar
Der Urologe 46 (Suppl 1): S142, 2007